Your Cart ( 1 Item )

• A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne
  June 2019 | Volume 18 | Issue 6 | Original Article | 570 | Copyright © June 2019
  Alessandro Mazzetti MD,^a Luigi Moro PhD,^a Mara Gerloni PhD,^a Martina Cartwright PhD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs